INTRODUCTION
Salmonella is a Gram-negative bacterium, several strains of which are human pathogens. S. typhimurium is a major source of food-borne enterocolitis, whereas S. typhi is the etiological agent for typhoid fever, a disease that remains endemic in the developing world (Haraga et al., 2008) . A common feature of all pathogenic strains of Salmonella is the presence of Salmonella Pathogenicity Islands (SPIs) in their genome. Specifically, two of these (SPI-1 and SPI-2) encode for type III secretion systems (T3SS), large macromolecular assemblies responsible for the injection of toxic ''effector'' proteins into the cytosol of infected cells (Coburn et al., 2007a; de Jong et al., 2012) . T3SSs have been identified as essential pathogenicity components in many infectious Gram-negative bacteria, including Salmonella spp., enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli, Pseudomonas aeruginosa, Yersinia spp., Shigella spp., Chlamydia spp., and Vibrio spp. (Coburn et al., 2007b; Troisfontaines and Cornelis, 2005) . This renders the T3SS a very attractive target for the development of new antibiotics and vaccines (Keyser et al., 2008; Kline et al., 2012; Marshall and Finlay, 2014) .
A T3SS consists of a series of conserved genes coding for the secretion apparatus (''injectisome'') and of a set of genes coding for the effector proteins, which vary between systems and species (Bü ttner, 2012; Kosarewicz et al., 2012) . Effector proteins are channeled through the injectisome to the cytosol of target cells (Dohlich et al., 2014; Radics et al., 2014) . A number of groups have employed an integrative approach (Alber et al., 2008) to obtain structural models of the prototypical Salmonella SPI-1 T3SS injectisome. Electron microscopy (EM) studies have revealed its global organization (Marlovits et al., 2004; Schraidt et al., 2010; Schraidt and Marlovits, 2011) , and the atomic structures of several isolated domains have been reported (Bergeron et al., 2013; Lunelli et al., 2011; Spreter et al., 2009; Wang et al., 2007) . Cross-linking in combination with mass spectrometry was employed to obtain information on the interaction between the various components Schraidt et al., 2010) . Finally, computational methods have been developed to combine these data in order to obtain an atomic model of the T3SS injectisome architecture (Bergeron et al., 2013; Demers et al., 2013) .
However, the mechanistic details for the assembly of this large complex ($3.5 MDa) remain poorly understood. Genetic, biochemical, and EM data have demonstrated that the innermembrane components of the injectisome can assemble independently, with the proteins PrgK and PrgH ( Figure 1A ) forming intimately nested 24-mer ring structures around the inner-membrane components SpaPQRS (Kimbrough and Miller, 2000; Wagner et al., 2010) . Biochemical data also showed that in parallel the secretin InvG forms a pore in the outer membrane (Figure 1A) , facilitated by the action of the pilotin lipoprotein InvH (Crago and Koronakis, 1998; Okon et al., 2008; Spreter et al., 2009) . The inner-membrane and outer-membrane components are proposed to come together through interactions of their periplasmic domains and to then recruit the cytoplasmic ATPase complex, leading to a secretion-competent complex Schraidt et al., 2010) .
In this study, we use structural, biochemical, and functional methods to investigate the assembly of the prototypical Salmonella SPI-1 T3SS inner-membrane component, PrgK. We report the structures of its two globular domains, and we use computational methods to propose a model for the PrgK-PrgH interaction in the assembled basal body (the major T3SS injectisome subcomplex isolated from bacteria and composed largely of the inner and outer membrane ring components PrgH, PrgK, and InvG; see Figure 1A ). This model suggests that each PrgH monomer docks in between adjacent PrgK subunits. We also show that a linker region of PrgK may regulate oligomerization through multiple interactions with the flanking globular domains. Based on these results, we propose a molecular model for the stepwise assembly of the PrgK-PrgH inner-membrane ring.
RESULTS

Elucidating the Roles of PrgK's Membrane-Embedded Domains
PrgK is an inner-membrane component of the Salmonella SPI-1 T3SS basal body (Kimbrough and Miller, 2000) ( Figure 1A) . At its N terminus, PrgK possesses a canonical lipoprotein signal sequence, with a conserved cysteine residue (Cys 18) forming a predicted site of lipidation (Juncker et al., 2003) . Lipidation has been experimentally confirmed in vivo for the closely related Shigella ortholog MxiJ (44% sequence identity) (Allaoui et al., 1992) . In addition, a C-terminal transmembrane (TM) helix is predicted in all PrgK orthologs, except the EPEC T3SS component EscJ ( Figure 1B ; Figure S1A available online). Nanogold labeling experiments have shown that the C terminus of PrgK is located in the cytoplasm, confirming that PrgK traverses the inner membrane (Schraidt et al., 2010) .
To assess the role of the putative N-terminal lipidation and C-terminal TM helix for basal body assembly, we monitored secretion of effector proteins in a S. typhimurium strain containing a chromosomal deletion of the prgK gene and complemented with plasmids encoding WT prgK or mutants. Surprisingly, removal of the C-terminal 52 residues, which include the cytoplasmic tail and TM helix (PrgK 1-200 ), does not alter effector secretion ( Figure 1C ). This observation demonstrates that the TM helix of PrgK is not essential for inner-membrane localization or basal body assembly. In contrast, secretion is abrogated when the putative N-terminal lipidation site is mutated (C18A), suggesting a requirement for the specific anchoring of PrgK to the inner membrane via lipidation of Cys 18.
Following from the above observations, we were able to purify intact needle complexes from Salmonella strains lacking the TM helix of PrgK, as observed by negative-stain EM (Figures S1B and S1C). We note that the yield of complexes obtained with the PrgK 1-200 truncation is approximately 10-fold lower than with the WT PrgK. This suggests that the TM helix does contribute to the overall stability of the needle complex.
Structures of the PrgK Globular Domains
Existing homology models of the PrgK ring structure Schraidt and Marlovits, 2011; Worrall et al., 2011) are based on the experimental observation of a superhelical array of 24-mer containing successive turns found in the crystal structure of the EPEC ortholog, EscJ (26% identity) (Yip et al., 2005) . However, we showed previously that ring models of basal body domains based on the structures of distant homologs lead to inaccuracies, including domain misorientation and clashes, and interfered with model convergence in our EM-guided symmetry modeling procedure (Bergeron et al., 2013) . Therefore, in order to obtain a more accurate PrgK ring model, the experimentally determined structure of the PrgK monomer was required. To this end, we expressed a recombinant construct of its periplasmic domain lacking the lipidation site ). This protein could be purified to high yield, but underwent proteolytic degradation at 20 C (hours) and 4 C (days), leading to two products of approximately 14 and 9 kDa size, respectively (data not shown). Crystal and solution structures of EPEC EscJ (Crepin et al., 2005; Yip et al., 2005) have revealed that this homologous protein possesses two globular domains (7 and 10 kDa) joined by an extended linker ( Figures 1B and S1A ). We therefore purified the two corresponding globular domains of PrgK independently. We could not obtain crystals for the N-terminal domain , henceforth referred to as D1). However, this protein yielded high-quality nuclear magnetic resonance (NMR) spectra (Figure 2A ), allowing us to solve its solution structure ( Figure 2B ; Table 1 ). Further, we were successful in obtaining crystals of the C-terminal domain , henceforth D2) and could solve its structure by X-ray crystallography ( Figure 2C ; Table 2 ; see Supplemental Experimental Procedures for details).
The folds of the PrgK D1 and D2 domains are similar to those of the equivalent domains in the EPEC T3SS ortholog EscJ (Figure S2) , with backbone RMS deviations <1.5 Å . Both D1 and D2 possess the canonical ring-building motifs observed in other components of the T3SS basal body (Bergeron et al., 2013; Spreter et al., 2009) . We note that the first strand (termed b0 here for consistency) of EscJ D1 is not observed in PrgK, possibly due to a single residue insertion at position 23 based on the sequence alignment ( Figure S1A ), which either destabilizes or prevents its formation. In addition, PrgK D2 possesses (C) X-ray crystallographic structure of PrgK D2, in a ribbon representation, with corresponding sequence numbering shown. Dashed line indicates residues not resolved in the electron density. For (B) and (C), secondary structure elements are labeled as in Figure S1A , and blue to red rainbow coloring indicates N-to C-terminal directionality. See Tables 1 and 2 for statistics and also Figure S2 .
a six-residue insertion (from 136-141) in a loop region between strands b3 and b4 relative to EscJ (Figures S1A and S2) . This insertion is only partially ordered in the PrgK D2 crystal structure (Figures 2C and S2; see Supplemental Experimental Procedures for details).
Modeling of the PrgK 24-mer Ring
We next applied our NMR and crystallographic structures to an EM-guided symmetry modeling protocol (Bergeron et al., 2013) to model the PrgK 24-mer ring oligomer. Starting from the monomeric structures of D1 and D2, we applied the procedure to the two domains independently ( Figure S3 ; Supplemental Experimental Procedures for details), allowing us to obtain a refined model for PrgK ( Figure 3A) . Notably, despite this independent starting set, the final model is globally similar in intermolecular packing to the intact EscJ ring model derived from the crystallographically determined superhelical structure ( Figures S3C and S3D) , with both domains in each of these orthologs adopting similar orientations. We further note that the diameter of the D2 ring is larger in the PrgK model, in agreement with the dimension of the region of density assigned to PrgK in the EM map. It has been reported that the EPEC T3SS possesses a narrower basal body compared with the Salmonella SPI-1 T3SS (Sekiya et al., 2001) , suggesting that the larger PrgK D2 ring may correspond to structural differences between the two systems.
We then observed that in the Rosetta-based PrgK model, the D1 and D2 domains are in close proximity, forming a number of notable direct interactions, including between residues 70-75 at the surface of helix a2 of D1, and residues 111-126 on a4 and strand b3 of D2 ( Figure 3B ). This prompted us to investigate whether the D1 and D2 domains of PrgK interact in vitro. Using NMR spectroscopy, we monitored spectral perturbations in the 15 N-labeled D1 domain upon titration with unlabeled D2. As shown in Figure 3C , we could observe a number of amide 1 H-15 N with progressively perturbed chemical shifts, implicating residues 70-74 of helix a2, and to a lesser extent, those in the spatially adjacent helix a1 (residues 38-42). These are largely hydrophobic residues, which cluster on the surface of D1 formed by the two helices of the domain ( Figure 3D ) and match with the interface generated in the PrgK 24-mer model ( Figure 3B ). In parallel, a weak endothermic reaction was observed when we used isothermal titration calorimetry (ITC) to monitor the titration of D1 against D2 ( Figure 3E ). However, over the available concentration range, we were unable to saturate the ITC-and NMR-monitored titration, indicating that it is a weak interaction with an affinity likely in the millimolar range ( Figure 3C ). Nevertheless, this interaction is specific, as evidenced by its abrogation when Tyr70 (a residue in helix a2 that is perturbed in the NMR titrations; Figure 3C ) is mutated to Ala ( Figure 3E ). Collectively, these experiments both confirm that the isolated D1 and D2 domains do interact and identify the D1 a1-a2 surface as the primary constituent of the D1-D2 interface ( Figure 3D ). Importantly, this matches the interface generated in the PrgK 24-mer model ( Figure 3B ). We emphasize that that the weak intermolecular interaction of the isolated D1 and D2 is not unexpected given that the two are removed from their native intramolecular arrangement. In addition, cooperativity within the 24-mer may ''amplify'' the interaction.
The Linker Region of PrgK Promotes Oligomerization
We further noted that the residues involved in the D1-D2 interaction identified in PrgK (Figure 3 ) are also present in the EscJ superhelix crystal structure ( Figure 4A ). However, in the latter, we observed that this interaction occurs between adjacent molecules, with D1 of molecule i interacting with D2 of molecule i+1 along the 24-mer oligomeric ring (we refer to this arrangement as a ''domain-swapped'' conformation). This is likely driven by the linker region, which is well ordered and forms a number of interactions with D2 ( Figure 4B ), but not with D1 or with linker regions from adjacent molecules. As we have modeled the two domains D1 and D2 of PrgK independently, we cannot directly distinguish whether the analogous D1-D2 interaction occurs in an intermolecular domain-swapped conformation ( Figure 4C , right), as opposed to an intramolecular interaction between domains within a single chain ( Figure 4C , left).
To answer this question, we engineered a construct of PrgK D2 containing the upstream linker region ). Unexpectedly, we observed that this protein forms a large homo-oligomeric complex, as shown using size-exclusion chromatography with multiangle light scattering (SEC-MALS) ( Figure 5A , brown curve), whereas in the absence of the linker, D2 is monomeric (purple curve). Importantly, the fold of D2 is likely globally conserved in the PrgK 82-200 construct, as shown by CD spectroscopy ( Figure S4A ), supporting that this oligomer is not constituted of unstructured, aggregated protein. A closer analysis of the EscJ superhelix structure revealed that a conserved Phe at position 89 in the linker region docks into a hydrophobic pocket formed by two adjacent D2 subunits ( Figure 5B ). We therefore Figure 5A , green curve) in vitro, confirming that the linker promotes D2 oligomerization in a similar fashion to that observed in the EscJ superhelix structure. We note that this mutation does not compromise T3SS secretion in vivo, nor does the Y70A mutation (which disrupts the oligomeric interaction between D1 and D2, see above). However, the double-mutant F89A/Y70A does abrogate secretion ( Figure S4C ), which suggests that PrgK oligomerization is likely stabilized by a number of interactions, including those involving residues Phe89 and Tyr70. The NMR spectrum of PrgK with the Y70A/F89A mutations ( Figure S4D ) confirmed that the overall fold of the protein is conserved, and its stability was confirmed by differential fluorescence calorimetry ( Figure S4B ). Further structural characterization of this protein was not possible due to its propensity to undergo degradation (see above). (D) These residues are shown in sticks on the D1 structure and clearly match with residues that form contacts with D2 in (B).
(E) ITC isotherms for the titration of PrgK D1 against PrgK D2. A weak (mM range) endothermic interaction is observed between D1 and D2 (left), which is disrupted when the Y70A mutation is introduced to D1 (right). See also Figure S3 .
Finally, we used negative-stain EM to analyze the PrgK 82-200 oligomer and observed that it forms ring-shaped/ tubular structures, with a conserved diameter of $15-20 nm ( Figure 5C ). This diameter is similar to that observed in both the EscJ superhelix structure (Yip et al., 2005) and in the density attributed to the PrgK ring in the high-resolution cryo-EM map of the basal body (Schraidt and Marlovits, 2011) . However, the structures vary in length from a few nm to over 100 nm ( Figure 5C ). Based on these observations, we propose that these filaments consist of a superhelical assembly of PrgK D2, which putatively forms in the absence of the membrane-embedded N-terminal lipidation that would restrict its assembly to a 2D plane. We note that the heterogeneous nature of these structures prevented any high-resolution characterization, as would be required to formally demonstrate their biological significance.
From these results, we conclude that in the EPEC EscJ and Salmonella PrgK inner-membrane rings D1 and D2 likely form a domain-swapped interface between adjacent molecules. We hypothesize that this allows for a more extensive set of interactions within the 24-mer rings, including with the linker region, to promote oligomerization.
Interaction between D1 and Linker Prevents Oligomerization
We have demonstrated that the linker is sufficient to promote oligomerization of D2 in vitro, in the absence of D1. However, no oligomerization was observed for the PrgK 19-200 construct, which includes D1, D2, and the linker ( Figure 5A, blue curve) . This suggested the possibility that D1 may prevent spontaneous and potentially premature oligomerization of PrgK in the inner membrane.
To validate this hypothesis, we engineered a protein construct including D1 followed by the linker region ). Using ITC, we observed that the D1-D2 interaction is abrogated in the context of the D1-linker construct ( Figure 6A ). To understand how the presence of the linker residues abrogates this interaction, we used NMR spectroscopy to characterize PrgK further. Unexpectedly, we observed that many residues yield two distinct sets of NMR signals ( Figure 6B ), indicative of two conformations in slow exchange, referred to as ''population A'' and ''population B,'' with the peaks yielded by population A consistently more intense than those yielded by population B. We mapped chemical shift differences between these two populations along the sequence, which inferred that structural differences occur primarily in the a helices and the following linker ( Figure 6C) . However, the chemical shift-derived secondary structure prediction suggests that population A and population B possess similar secondary structure elements. The Random Coil Index (Berjanskii and Wishart, 2007) also reveals that residues 70-82 (end of helix 2 and beginning of the linker) are less flexible in population A than in population B ( Figure 6C ). We note that most peaks found in the spectrum of PrgK D1 overlay onto the peaks assigned to population B of PrgK (Figure S5A) , indicating that in population B the linker does not interact significantly with the D1 domain. These results suggest that in population A, residues 76-82 of the linker interact with D1, while this interaction is not present in population B. Importantly, the spectrum of PrgK 19-92 overlay well onto that of the construct that included both PrgK domains Figure S5B) , with the two peaks formed by population A and population B clearly observable in the larger construct. This demonstrates that the interaction between D1 and the linker is also present in the purified, monomeric full-length protein (lacking the N-terminal lipidation site and C-terminal TM region), which could not be characterized further due to its instability (see above).
Next, we were able to solve the crystal structure of PrgK 19-92 ( Figure 6D ; Table 2 ; see Supplemental Experimental Procedures for details). In this structure, part of the linker (residues 75-82) is well ordered and clearly located in the D2-binding groove of D1, in agreement with the NMR results described above. Notably Tyr 75, Leu 77, and Pro 78 form hydrophobic interactions with loop 1, helix a1, and helix a2 of D1 ( Figure 6E ). We note that only the linker-bound conformation, corresponding to population A, was found in the crystal. It is also noteworthy that this protein forms a superhelical arrangement in the crystal lattice, in which intermolecular contacts supports the D1 ring model reported above (Figures S5C and S5D) . Together, these results demonstrate that D1 interacts with the linker, through the groove formed in between the two helices of the domain. This corresponds to the surface of D1 that interacts with D2, as shown by our modeling and NMR results (see Figures 6C and 3D) . From this observation, we conclude that the linker interacts with the D2 binding pocket of D1, thereby sterically blocking the D1-D2 interaction. Furthermore, by sequestering the linker, D1 likely also prevents spontaneous oligomerization of PrgK.
To provide additional support for this hypothesis, we used NMR spectroscopy to monitor the titration of PrgK D1 with an isolated polypeptide corresponding to the linker sequence (PrgK 76-97 ) fused to SUMO. As summarized in Figure S5E , a number of D1 residues showed amide chemical shift changes upon peptide addition. These residues clustered around the helical regions of D1 ( Figure S5G ). This confirms that the linker binds the same region of D1, whether present as a separate peptide or in the intramolecular context of PrgK . Furthermore, chemical shift analysis ( Figure S5F ) allowed us to obtain a K d value of 100 mM (±40 mM) for the intermolecular D1-linker interaction. This is at least an order of magnitude tighter than the intermolecular D1-D2 interaction. The preferential D1-linker interaction is consistent with the observations by NMR and SEC-MALS that PrgK 19-200 is monomeric.
Structural Basis for the PrgH-PrgK Interaction
We next combined the 24-mer models of PrgK D1 and D2 described above ( Figure 3A) , with the PrgH oligomeric model reported previously (Bergeron et al., 2013) , and applied the ring Residues 86-89 form a short helix, which interacts with D2. (C) Ribbon representation of successive molecules in our PrgK D1 and D2 model, colored as in (A). Two possible chain assignments can be made: interacting D1 and D2 domains can belong to the same chain and form intramolecular interaction identified with red arrows (left) or belong to adjacent chains and form a domain-swapped interaction (right). EscJ exhibits the latter, whereas in our PrgK model these two conformations are indistinguishable, as the linker (shown here with a dashed line) was not modeled. modeling procedure on the collective set (see Figures S6A and S6B; Supplemental Experimental Procedures for details). From this we obtained a model for the PrgH-PrgK 48-mer ring complex ( Figure 7A ), which agrees with the EM map ( Figure S6C ), and previously published biochemical data (Table S1 ). We emphasize that the model includes a number of assumptions, such that the subunits are related by strict symmetry, and that the structures of individual domains are not significantly modified in the assembled complex. Higher resolution EM maps, crystal structures of oligomerized domains, and additional mass spectrometry/crosslinking and mutagenesis interaction data should allow for generation of models with greater accuracy in the future. In particular, while the agreement with the NMR titration and EscJ crystallographic contacts supports the PrgK model, additional experimental restraints would be necessary to better define the PrgH-PrgK interaction.
In this model, we observe that there are predicted contacts between the periplasmic domains of PrgH and PrgK monomers ( Figure 7B ). However, this intermolecular interface is relatively limited (collectively 1,440 Å 3 of buried surface for the modeled complex) and with the major interactions occurring between the C-terminal region of PrgH and PrgK D2. This is in agreement with the highest resolution ($10 Å ) EM map (Schraidt and Marlovits, 2011) , in which a large cavity is observed between the sections of the density attributed to PrgH and PrgK ( Figure 7B ). Specifically, in the PrgH-PrgK model, the conserved Asp 333 (located on helix 2 in the third ring-building motif domain of PrgH) is buried in a well-ordered, positively charged pocket formed by helix a4 of two adjacent PrgK D2 subunits ( Figure 7C ). Consistent with this arrangement, we were not able to detect an interaction between the periplasmic domain of PrgH and PrgK in vitro (data not shown), likely because this construct does not form the PrgH binding pocket in its monomeric state. The highly oligomeric and heterogeneous state of the PrgK 82-200 construct did not allow for further investigation of its interaction with PrgH. As shown in Figure 7D , mutation of Asp 333 to Arg in PrgH abrogates secretion (without affecting the structure of the isolated domain; Figures S6D and S6E ), supporting the essential role of this residue. In PrgK, mutation of the conserved Lys 168 to Glu does not alter secretion, but it is abrogated when both Lys 168 and Arg 169 are mutated to Ala. CD spectroscopy and differential scanning calorimetry (DSF) suggest that PrgK D2 is largely folded in the presence of these mutations (Figures S6F and S6G) . We also observe that the loop located between strand b5 and helix a5 of D2, which is poorly ordered in the PrgK crystal structure (see Supplemental Experimental Procedures), is located in the cavity described above ( Figure 7B ) in our PrgK ring model. Neither this loop nor the extended loop between strands b4 and b5 is accounted for by EM map density. It is therefore possible that flexible regions of PrgK could potentially form additional contacts with PrgH upon complex formation.
DISCUSSION
In this study, we characterize structural and functional features of the modular ring building domains of the inner-membrane protein PrgK, from the prototypical Salmonella SPI-1 T3SS injectisome. We demonstrate that its C-terminal TM helix is not essential for injectisome assembly/effector secretion and report the crystallographic and NMR structures of its two globular domains in isolation. Using our previously developed molecular modeling method combining atomic structures of individual domains, EM maps, and symmetry, we have obtained a model of the PrgK periplasmic ring. Further analysis in the context of its binding partner PrgH provides a starting point for understanding the intimate molecular interaction between these two ring-forming proteins. Finally, we propose that the linker region between the two globular ringbuilding domains of PrgK may play a regulatory role in oligomerization, by promoting an intermolecular, domain-swapped disposition of D1 and D2 that stabilizes the 24-mer ring complex. Previous studies have shown that coexpression of PrgK and PrgH leads to the spontaneous formation of the inner-membrane ring structures. In contrast, expression of PrgK or PrgH alone forms oligomers, but lacks the ring-like conformation observed in the fully assembled injectisome (Kimbrough and Miller, 2000) . In this light, the data reported here suggest a molecular mechanism for the assembly of the PrgH-PrgK rings. We propose that PrgK can adopt two conformations: an assemblyincompetent conformation with D1 sequestering the linker and an assembly-competent conformation where the linker promotes oligomerization. This conformation is likely stabilized by the insertion of a PrgH molecule in between two adjacent PrgK (Marsh et al., 2006) , is shown in the middle. Scores of +1, 0, and À1 correspond to helices, random coils, and strands, respectively. The Random Coil Index profiles for the populations A and B of PrgK 19-92 , obtained from their assigned 1 H N , 15 N, 13 C a , and 13 C b chemical shifts using the RCI server (Berjanskii and Wishart, 2007) , are shown at the bottom. Residues 72-84 are less disordered in population A than in population B.
(D) Crystal structure of PrgK 19-92, in ribbon representation, with corresponding sequence numbering shown. Secondary structure elements are labeled as in Figure S1A , and blue to red rainbow coloring indicates N-to C-terminal directionality (see Table 2 for statistics).
(E) Close-up view of the linker region (in red) interaction with D1 (green). The composite 2Fo-Fc omit map (0.05% atoms omitted, generated by Phenix) is shown, contoured at 1 s around residues 75-82. Residues that form hydrophobic interactions between D1 and the linker are shown as sticks. See also Figure S5 .
molecules, which would explain why PrgK or PrgH alone do not spontaneously form ring-like oligomers. Propagation of this ring-initiation step leads to the formation of a stable PrgH-PrgK 24-mer ring pair (Figure 8 ). We argue that such a coordinated oligomerization of these two conserved luer lock rings would be essential to allow their formation only upon encompassing the several inner-membrane spanning export apparatus proteins that they are presumed to contain (Wagner et al., 2010) . We acknowledge that this proposed mechanism is derived largely from the biochemical and structural behavior of a soluble, monomeric fragment of PrgK and may therefore not reflect the behavior of the full-length membrane-embedded protein in vivo. However, the correlation between the impact of PrgK mutations in vitro and in vivo, as well as the ability to isolate a PrgH/K complex (Kimbrough and Miller, 2000) , supports the validity of the proposed model. Although perhaps intuitively sensible that a large complex such as the PrgK-PrgH oligomer would assemble in a coordinated, step-wise manner, additional experimental validation, such as the isolation and molecular characterization of assembly intermediates, will be required to confirm the model proposed in Figure 8 .
A second aspect of this study is the proposed model for the PrgH-PrgK interaction from our Rosetta-based analysis. Perhaps surprising is the somewhat limited nature of this interface that, although bolstered by stoichiometry, suggests additional functionalities, such as the lipidated and/or membrane-spanning regions of PrgH and PrgK, may also play a role. Alternatively, the presence of peptidoglycan, cytoskeleton, or other structural components in the periplasm may also act in stabilizing the complex in the membrane environment. Further, both the EM map density and our symmetry modeling suggest the presence of a large cavity between PrgH and PrgK (Figure 7) , with few interactions occurring in the periplasmic region (although it is possible that in situ this cavity is occupied by other components of the injectisome that perhaps are lost during needle complex purification in the EM analysis). This cavity could In PrgH, mutation of Asp 333 abrogates secretion, while in PrgK mutation of Lys 168 to Glu has no phenotype, but secretion is abrogated when both Lys 168 and Arg 169 are mutated to Ala. These results support the essential role of the proposed PrgH-PrgK interface in T3SS assembly. We note that protein levels are decreased for all mutants compared with WT, likely caused by increased protein turnover in the absence of complex formation (Schraidt and Marlovits, 2011) . See also Figure S6 and Table S1 .
allow for a degree of structural plasticity in the basal body, as observed recently in situ for the Yersinia T3SS (Kudryashev et al., 2013) . The presence of a cavity into which solvent can diffuse between PrgH and PrgK could also have favorable implications in the design of T3SS assembly inhibitors.
In conclusion, in this study, we have obtained the structures of isolated domains of PrgK and used interaction studies and computational methods to propose a structural model for the PrgH-PrgK 48-mer periplasmic rings. This provides insights into the interaction between PrgH and PrgK. We also report biochemical, structural, and functional data suggesting a stepwise assembly for the PrgH-PrgK complex, promoted by structural rearrangement in PrgK. While integrative structural biology approaches enable the piecing together of the architecture of large macromolecular assemblies, the addition of a temporal dimension, including assembly, disassembly, and/or functional changes, such as that probed here, is an important further element toward understanding and targeting complex nanomachines such as the T3SS at the molecular level.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
All constructs were cloned in a pET28a plasmid (Novagen), with an N-terminal His 10 -tag fusion followed by a thrombin cleavage site. Plasmids were transformed into E. coli BL21(DE3) cells, and transformants were grown to log phase at 37 C. Expression was induced with 1 mM isopropyl b-D-1-thiogalac- C-labeled glucose. The proteins were purified as above.
NMR Spectra Acquisition, Assignment, and Structure Determination For all NMR experiments, protein samples were dialyzed into 50 mM HEPES (pH 6.8), 10% D 2 O, and concentrated to $0.5-1 mM. Standard 2D and 3D spectra for backbone and side-chain assignments were collected using either a 600 or 850 MHz Brucker Avance III spectrometer, equipped with TCI cryoprobe. All spectra were processed using NMRPipe (Delaglio et al., 1995) and analyzed with SPARKY (T.D. Goddard and D.G. Kneller, University of California, San Francisco) (see Supplemental Experimental Procedures for details).
Crystallization and X-Ray Crystallographic Structure Determination Crystals of PrgK and PrgK 19-92 were obtained in 100 mM sodium acetate (pH 5.5), 20% polyethylene glycol (PEG) 6000, 50 mM NaCl, 50 mM MgCl 2 , and 80 mM phosphate buffer (pH 4.0), 20 mM Tris pH 7.0, 25% PEG 300, 20 mM MgCl2, 20 mM NaCl, respectively, by vapor diffusion, using the sitting drop method. X-ray diffraction data were collected at the Canadian Light Source beamline 08B1-1. Phases were obtained by molecular replacement with the program Phaser (McCoy et al., 2007) . The PrgK 98-200 structure was refined to 2.65 Å resolution and the PrgK 19-92 to 3.2 Å resolution (Table 2 ; see Supplemental Experimental Procedures for details).
EM-Guided Symmetrical Modeling
Ring modeling for PrgK D1 and PrgK D2 was performed as described previously (Bergeron et al., 2013 ; see Supplemental Experimental Procedures for details).
For the PrgK D1-D2-PrgH model, individual lowest energy ring models of PrgK D1, PrgK D2, and PrgH were combined into a single coordinate file and used to generate the input for the phase II all atom refinement procedure (see Supplemental Experimental Procedures for details).
In Vivo Assays
Salmonella typhimurium LT2 strains containing a deletion of the prgH or prgK gene were complemented with plasmids containing the corresponding gene or mutants, all with a C-terminal 6xHis tag, which does not affect T3SS function (Schraidt et al., 2010) , and effector protein secretion was monitored as described previously (Kimbrough and Miller, 2000) . Needle complexes were purified as described previously (Bergeron et al., 2013; Kubori et al., 1998; Schraidt et al., 2010) .
Electron Microscopy
Samples of PrgK 82-200 were diluted to $1 mg/ml in 50 mM HEPES (pH 7.0), 150 mM NaCl. Samples of purified needle complex particles were diluted to $0.2 mg/ml in 10 mM Tris (pH 8.0), 500 mM NaCl, 5 mM EDTA, and 10 mM lauryldimethylamine oxide. All samples were applied on glow-discharged carbon grids and stained using 0.75% uranyl formate. Images were collected on a Technai G2 transmission electron microscope (FEI) operating at 200 kV and equipped with a high-speed AMT 2K side-mount CCD camera. 
ACCESSION NUMBERS
The atomic coordinates for the various structures have been deposited in the PDB ID (2MKY, 4OYC, and 4W4M). The lowest all-atom energy PrgH-PrgK Rosetta model has been deposited in the PDB (3J6D). 
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